United States· US:83709-001_9db61e18-114c-46c5-bdc2-5f56c4b2f87f
XTORO
A medicinal product containing finafloxacin, registered in United States by Fonseca Biosciences, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FINAFLOXACIN
- Manufacturer
- Fonseca Biosciences, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1183709-001-01
- ndc1183709-001-90
- ndc1183709-001-91
- ndc1183709001011 BOTTLE, DROPPER in 1 CARTON (83709-001-01) / 5 mL in 1 BOTTLE, DROPPER
- ndc1183709001901 POUCH in 1 CARTON (83709-001-90) / 1 BOTTLE, DROPPER in 1 POUCH / 1.5 mL in 1 BOTTLE, DROPPER
- ndc1183709001911 BOTTLE, DROPPER in 1 CARTON (83709-001-91) / 5 mL in 1 BOTTLE, DROPPER
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1dad3a0-bc6e-4266-b4e9-f0c5f673576d GET /v1/drugs/b1dad3a0-bc6e-4266-b4e9-f0c5f673576d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "AURICULAR (OTIC)",
"source": "ndc",
"strength": "3",
"substance": "FINAFLOXACIN",
"productndc": "83709-001",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA206307",
"marketing_category": "NDA"
}See everything about finafloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.